Literature DB >> 3124981

Determination of fecal alpha 1-antitrypsin concentration by radial immunodiffusion: two systems compared.

C M Wilson1, K McGilligan, D W Thomas.   

Abstract

We compared Helena "QUIPlates" and Calbiochem "LC-Partigen" radial immunodiffusion systems for their ability to measure fecal concentrations of alpha 1-antitrypsin (FA1AT). Reference ranges for FA1AT concentrations in infants receiving various diets, in children, and in adults are given for each system. FA1AT values obtained with Calbiochem LC-Partigen plates averaged 30% greater than those obtained with Helena QUIPlates, but both systems distinguished between normal and high values. Studies involving variations of usual sample-handling procedures showed that storage at room temperature, repeated freezing and thawing, and long-term storage of frozen samples had no significant effect on measured FA1AT concentration. However, values obtained for lyophilized and nonlyophilized samples did not correlate well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124981

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Fecal excretion of alpha 1-antitrypsin in patients with Crohn's disease. A comparison of nephelometry and radial immunodiffusion.

Authors:  A López; J Hinojosa; A Miralles; J Primo; J D Bermúdez
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

2.  Serum proteins in the haemolytic uraemic syndrome.

Authors:  G Goos; P Declercq; W Proesmans
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

3.  Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.

Authors:  M Boirivant; F Pallone; A Ciaco; M Leoni; S Fais; A Torsoli
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

4.  Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.

Authors:  Thomas C C Boerlage; Floris Westerink; Dennis C W Poland; Inge L Huibregtse; Yair I Z Acherman; Victor E A Gerdes
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.